EcoDrugPlus

Toll Like Receptor 7

Ensembl ID : ENSPEMG00000000676
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSPEMG00000001415
Gene Symbol: TLR8
3 Cross references
200 Possible Orthologues:

Toll-Like Receptor 9

Ensembl ID : ENSPEMG00000016808
Gene Symbol: TLR9
1 Cross references
82 Possible Orthologues:

Topoisomerase (Dna) Ii Alpha

Ensembl ID : ENSPEMG00000016393
Gene Symbol: TOP2A
1 Cross references
209 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSPEMG00000022856
Gene Symbol: TAAR1
3 Cross references
602 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSPEMG00000027439
Gene Symbol: TGFBR1
3 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSPEMG00000011394
Gene Symbol: TRPA1
3 Cross references
226 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSPEMG00000017952
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily M, Member 8

Ensembl ID : ENSPEMG00000022258
Gene Symbol: TRPM8
1 Cross references
158 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSPEMG00000020791
Gene Symbol: TSPO
3 Cross references
126 Possible Orthologues:

Transthyretin

Ensembl ID : ENSPEMG00000024235
Gene Symbol: TTR
3 Cross references
164 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSPEMG00000011560
Gene Symbol: TPH1
3 Cross references
255 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).